Get the Stockscreener App
0.3557
15.00%
0.051
In 8 Bio Inc stock is traded at $0.3557, with a volume of 2.10M.
It is up +15.00% in the last 24 hours and up +33.08% over the past month.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
See More
Previous Close:
$0.3047
Open:
$0.3047
24h Volume:
2.10M
Relative Volume:
2.11
Market Cap:
$24.39M
Revenue:
-
Net Income/Loss:
$-30.01M
P/E Ratio:
-0.2916
EPS:
-1.22
Net Cash Flow:
$-23.94M
1W Performance:
+27.60%
1M Performance:
+33.08%
6M Performance:
-64.96%
1Y Performance:
-66.31%
1-Day Range:
$0.3001
$0.4042
1-Week Range:
$0.2621
$0.41
52-Week Range:
$0.217
$2.48
In 8 Bio Inc Stock (INAB) Company Profile
Name
In 8 Bio Inc
Sector
Industry
Phone
(646) 600-6438
Address
EMPIRE STATE BUILDING, NEW YORK
In 8 Bio Inc Stock (INAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-30-22 | Initiated | H.C. Wainwright | Buy |
In 8 Bio Inc Stock (INAB) Latest News
2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - StockTitan
bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies - Yahoo Finance
OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc - Yahoo Finance
Highbridge Capital Management's Strategic Acquisition of INmune Bio Inc Shares - Yahoo Finance UK
Upstream Bio Rings the Opening Bell - Nasdaq
Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development - Yahoo Finance UK
TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - Yahoo Finance
MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum - Lelezard
Average rate on a 30-year mortgage in the US rises to the highest level in 8 weeks - Yahoo Finance
Cresco Labs to Report Third Quarter 2024 Financial Results on November 8, 2024 - Yahoo Finance
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings - Yahoo Finance
Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? - Yahoo Finance
FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer's Studies, Paving the Way to NDAs - Quantisnow
Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock? - Yahoo Finance
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - BNN Bloomberg
Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna - MSN
Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35 - Insider Monkey
Cellipont Bioservices and Mongoose Bio Sign Agreement to Advance MGB-001, its Lead TCR-T therapy, towards the Clinic for Multiple Cancers - Longview News-Journal
Jim Wilson’s new gene therapy company Gemma is getting up to $100M from Brazil - The Philadelphia Inquirer
Paramount Global to Report Third Quarter Financial Results on November 8, 2024 - Yahoo Finance
SK Bioscience's U.S.-based bio company 'Pina Bio'It announced on the 8th that it has signed a contra.. - 매일경제
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - BioSpace
Adicet Bio, Inc.'s (NASDAQ:ACET) large institutional owners must be happy as stock continues to impress, up 11% over the past week - Simply Wall St
If you bought this Breyers ice cream flavor in the past 8 years, you may be eligible for compensation - Yahoo Finance
Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Down 5.8% in September - Defense World
Adicet Bio to Present at the American Society of Gene & Cell Therapy’s (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference - Business Wire
A group of women lowered their biological age by an average of 5 years in just 8 weeks. Here’s how - Yahoo Finance
Biomarker Data from Oncology Trial for Adicet Bio’s Game Delta T-cell Therapy ADI-001 Indicates Potential for Use in Autoimmune Disease - CGTLive™
bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025 - Business Wire
Analysts’ Weekly Ratings Changes for Adicet Bio (ACET) - Defense World
Bluebird Bio to Cut 25% of Staff Amid Gene Therapy Struggles - BNN Bloomberg
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference - ForexTV.com
Cigna scaling back Medicare Advantage footprint in 8 states next year - Yahoo Finance
8x8 Inc executive sells over $25k in company stock By Investing.com - Investing.com South Africa
8x8 CEO sells over $48k in company stock By Investing.com - Investing.com UK
New insider Divincenzo Jonathan P. claimed no ownership of stock in the company (SEC Form 3) - Quantisnow
Retina Society 2024: Population pharmacokinetic modeling and simulation of ocular clearance of aflibercept 8 mg and 2 mg - Ophthalmology Times
SEC Form 424B5 filed by INmune Bio Inc. - Quantisnow
Indian Immunologicals Signs Pact For Clinical Development Of Zika Vaccine - Afternoon Voice
Indian Immunologicals Sign Pact For Clinical Development Of Zika Vaccine - NDTV
Seven Aussie startups that raised $206 million this week (sort of) - SmartCompany
Owning 41% shares,institutional owners seem interested in Nuvation Bio Inc. (NYSE:NUVB), - Simply Wall St
SEC Form 4 filed by EVP, President, LSG Barry James - Quantisnow
Biotech startup Number 8 Bio bags $7 million to drive methane-busting mission - SmartCompany
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Chairman, President, and CEO Schwartz Norman D covered exercise/tax liability with 5,159 units of Bio-Rad A Common Stock and converted options into 10,477 units of Bio-Rad A Common Stock, increasing direct ownership by 1% to 438,238 units (SEC For - Quantisnow
Director Allison Schwartz converted options into 247 units of Bio-Rad A Common Stock and covered exercise/tax liability with 118 units of Bio-Rad A Common Stock, increasing direct ownership by 11% to 1,305 units (SEC Form 4) - Quantisnow
Natco Pharma invests USD 8 mn in bio-tech firm eGenesis - Business Standard
INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference - StockTitan
bluebird bio (BLUE) – Analysts’ Weekly Ratings Updates - Defense World
In 8 Bio Inc Stock (INAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):